These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

886 related articles for article (PubMed ID: 24863738)

  • 1. Use of in vitro data in developing a physiologically based pharmacokinetic model: Carbaryl as a case study.
    Yoon M; Kedderis GL; Yan GZ; Clewell HJ
    Toxicology; 2015 Jun; 332():52-66. PubMed ID: 24863738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bayesian calibration of a physiologically based pharmacokinetic/pharmacodynamic model of carbaryl cholinesterase inhibition.
    Nong A; Tan YM; Krolski ME; Wang J; Lunchick C; Conolly RB; Clewell HJ
    J Toxicol Environ Health A; 2008; 71(20):1363-81. PubMed ID: 18704829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholinesterase inhibition and depression of the photic after discharge of flash evoked potentials following acute or repeated exposures to a mixture of carbaryl and propoxur.
    Mwanza JC; Lyke DF; Hertzberg RC; Haber L; Kohrman-Vincent M; Li R; Pan Y; Lyles RH; Simmons JE; Macmillan DK; Zehr RD; Swank AE; Herr DW
    Neurotoxicology; 2012 Jun; 33(3):332-46. PubMed ID: 22353443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a physiologically based pharmacokinetic and pharmacodynamic model to determine dosimetry and cholinesterase inhibition for a binary mixture of chlorpyrifos and diazinon in the rat.
    Timchalk C; Poet TS
    Neurotoxicology; 2008 May; 29(3):428-43. PubMed ID: 18394709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of biochemical and behavioral effects of carbaryl and methomyl in Brown-Norway rats from preweaning to senescence.
    Moser VC; Phillips PM; McDaniel KL
    Toxicology; 2015 May; 331():1-13. PubMed ID: 25707986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between brain and plasma carbaryl levels and cholinesterase inhibition.
    Herr DW; Mwanza JC; Lyke DF; Graff JE; Moser VC; Padilla S
    Toxicology; 2010 Oct; 276(3):172-83. PubMed ID: 20708061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Species extrapolation of life-stage physiologically-based pharmacokinetic (PBPK) models to investigate the developmental toxicology of ethanol using in vitro to in vivo (IVIVE) methods.
    Martin SA; McLanahan ED; Bushnell PJ; Hunter ES; El-Masri H
    Toxicol Sci; 2015 Feb; 143(2):512-35. PubMed ID: 25410581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbaryl and 1-naphthol tissue levels and related cholinesterase inhibition in male Brown Norway rats from preweaning to senescence.
    Moser VC; Phillips PM; McDaniel KL; Zehr RD; MacMillan DK; MacPhail RC
    J Toxicol Environ Health A; 2013; 76(20):1151-67. PubMed ID: 24279816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PBPK models in risk assessment--A focus on chloroprene.
    DeWoskin RS
    Chem Biol Interact; 2007 Mar; 166(1-3):352-9. PubMed ID: 17324392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An age-dependent physiologically based pharmacokinetic/pharmacodynamic model for the organophosphorus insecticide chlorpyrifos in the preweanling rat.
    Timchalk C; Kousba AA; Poet TS
    Toxicol Sci; 2007 Aug; 98(2):348-65. PubMed ID: 17504771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative in vitro to in vivo extrapolation of cell-based toxicity assay results.
    Yoon M; Campbell JL; Andersen ME; Clewell HJ
    Crit Rev Toxicol; 2012 Sep; 42(8):633-52. PubMed ID: 22667820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reconstructing exposures from biomarkers using exposure-pharmacokinetic modeling--A case study with carbaryl.
    Brown K; Phillips M; Grulke C; Yoon M; Young B; McDougall R; Leonard J; Lu J; Lefew W; Tan YM
    Regul Toxicol Pharmacol; 2015 Dec; 73(3):689-98. PubMed ID: 26545325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscular and brain cholinesterase sensitivities to azinphos methyl and carbaryl in the juvenile rainbow trout Oncorhynchus mykiss.
    Ferrari A; Venturino A; Pechén de D'Angelo AM
    Comp Biochem Physiol C Toxicol Pharmacol; 2007 Sep; 146(3):308-13. PubMed ID: 17509940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity analysis on a physiologically-based pharmacokinetic and pharmacodynamic model for diisopropylfluorophosphate-induced toxicity in mice and rats.
    Chen K; Teo S; Seng KY
    Toxicol Mech Methods; 2009 Oct; 19(8):486-97. PubMed ID: 19788408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parameters for pyrethroid insecticide QSAR and PBPK/PD models for human risk assessment.
    Knaak JB; Dary CC; Zhang X; Gerlach RW; Tornero-Velez R; Chang DT; Goldsmith R; Blancato JN
    Rev Environ Contam Toxicol; 2012; 219():1-114. PubMed ID: 22610175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of in vivo developmental toxicity of all-trans-retinoic acid based on in vitro toxicity data and in silico physiologically based kinetic modeling.
    Louisse J; Bosgra S; Blaauboer BJ; Rietjens IM; Verwei M
    Arch Toxicol; 2015 Jul; 89(7):1135-48. PubMed ID: 24935252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermoregulatory response to an organophosphate and carbamate insecticide mixture: testing the assumption of dose-additivity.
    Gordon CJ; Herr DW; Gennings C; Graff JE; McMurray M; Stork L; Coffey T; Hamm A; Mack CM
    Toxicology; 2006 Jan; 217(1):1-13. PubMed ID: 16182429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and effects on serum cholinesterase activities of organophosphorus pesticides acephate and chlorpyrifos in chimeric mice transplanted with human hepatocytes.
    Suemizu H; Sota S; Kuronuma M; Shimizu M; Yamazaki H
    Regul Toxicol Pharmacol; 2014 Nov; 70(2):468-73. PubMed ID: 25158275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a hybrid physiologically based pharmacokinetic model with drug-specific scaling factors in rat to improve prediction of human pharmacokinetics.
    Sayama H; Komura H; Kogayu M; Iwaki M
    J Pharm Sci; 2013 Nov; 102(11):4193-204. PubMed ID: 24018828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and pharmacodynamics of chlorpyrifos and 3,5,6-trichloro-2-pyridinol in rat saliva after chlorpyrifos administration.
    Smith JN; Wang J; Lin Y; Klohe EM; Timchalk C
    Toxicol Sci; 2012 Dec; 130(2):245-56. PubMed ID: 22874420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.